FIELD: experimental medicine.
SUBSTANCE: invention refers to experimental medicine, namely pharmacology and traumatology. Bilateral ovariectomy is performed in female Wistar rats. On the next postoperative day, chondroitin sulphate 68.6 mg/kg is administered once a day intragastrically for 8 weeks. On 57th day of the experiment, osteoporotic fractures of the hip and shoulder are simulated, and the introduction of chondroitin sulphate in the specified dose is continued until 12 weeks after the beginning of the experiment.
EFFECT: due to antioxidant properties of the preparation, the method enables to slow down the development of osteoporotic disorders in hypoestrogenic conditions, which in turn creates favourable conditions for successful fracture consolidation.
1 cl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR CORRECTING OSTEOPOROSIS AND OSTEOPOROTIC FRACTURES WITH 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINIUM HYDROXYBUTANEDIOATE IN EXPERIMENT | 2021 |
|
RU2775439C1 |
METHOD FOR RESERVATROL AND ENALAPRIL BASED OSTEOPOROSIS CORRECTION AND FRAGILITY FRACTURE PREVENTION | 2010 |
|
RU2437160C1 |
METHOD FOR THE CORRECTION OF OSTEOPOROSIS AND OSTEOPOROTIC FRACTURES WITH 3-HYDROXY-2-ETHYL-6-METHYLPYRIDINIUM NICOTINATE IN EXPERIMENT | 2021 |
|
RU2763011C1 |
METHOD FOR CORRECTING BONE MICROCIRCULATION ACCOMPANYING EXPERIMENTALOSTEOPOROSIS AND UNDERLYING FRACTURES WITH USE OF COMBINATION OF L-ARGININE AND ENALAPRIL | 2013 |
|
RU2542424C1 |
METHOD OF CORRECTING MICROCIRCULATION IN BONE TISSUE WITH COMBINATION OF L-NORVALIN AND ROSUVASTATIN IN CASE OF EXPERIMENTAL OSTEOPOROSIS AND FRACTURES AT ITS BACKGROUND | 2013 |
|
RU2540927C1 |
METHOD OF CORRECTING MICROCIRCULATION IN BONE TISSUE WITH L-NORVALIN IN CASE OF EXPERIMENTAL OSTEOPOROSIS AND FRACTURES AT ITS BACKGROUND | 2013 |
|
RU2540926C1 |
METHOD FOR ROSUVASTATIN CORRECTION OF BONE MICROCIRCULATION IN EXPERIMENTAL OSTEOPOROSIS AND ACCOMPANYING FRACTURES | 2013 |
|
RU2538612C1 |
METHOD FOR CORRECTING BONE MICROCIRCULATION ACCOMPANYING OSTEOPOROSIS AND UNDERLYING FRACTURES WITH USE OF COMBINATION OF L-ARGININE AND LOSARTAN | 2013 |
|
RU2542425C1 |
METHOD FOR CORRECTION OF BONE TISSUE MICROCIRCULATON IN EXPERIMENTAL OSTEOPOROSIS AND ASSOCIATED FRACTURES WITH COMBINATION OF RECOMBINANT ERYTHROPOIETIN AND ROSUVASTATIN | 2013 |
|
RU2541184C1 |
METHOD FOR RESERVATROL-BASED OSTEOPOROSIS CORRECTION AND FRAGILITY FRACTURE PREVENTION | 2010 |
|
RU2437161C1 |
Authors
Dates
2024-12-18—Published
2024-05-21—Filed